LivaNova (LIVN) Net Income towards Common Stockholders (2014 - 2026)

LivaNova's (LIVN) quarterly Net Income towards Common Stockholders came in at $23.1 million in Q1 2026, up 107.07% year-on-year from $11.2 million in Q1 2025, and down 25.14% quarter-over-quarter from $30.9 million in Q4 2025.

LivaNova (LIVN) Net Income towards Common Stockholders (2014 - 2026) Analysis & Trends

LivaNova has disclosed Net Income towards Common Stockholders across 12 years of filings, most recently posting $23.1 million for Q1 2026.

  • Net Income towards Common Stockholders for Q1 2026 came in at $23.1 million, up 107.07% year-over-year; the trailing twelve-month figure through Mar 2026 was $108.0 million (up 148.63% YoY), and the FY2025 annual result was -$242.4 million, down 483.26% from the prior year.
  • Net Income towards Common Stockholders came in at $23.1 million for Q1 2026 at LivaNova, down from $30.9 million in the prior quarter.
  • In the past five years, Net Income towards Common Stockholders ranged from a high of $55.9 million in Q4 2024 to a low of -$327.3 million in Q1 2025.
  • The 5-year median for Net Income towards Common Stockholders is $16.4 million (2023), against an average of -$13.2 million.
  • Across the five-year window, Net Income towards Common Stockholders surged 1283.09% in 2024 and slumped 680.83% in 2025, its largest moves.
  • LivaNova's Net Income towards Common Stockholders stood at $1.7 million in 2022, then surged by 867.81% to $16.4 million in 2023, then surged by 241.72% to $55.9 million in 2024, then sank by 44.69% to $30.9 million in 2025, then fell by 25.14% to $23.1 million in 2026.
  • The last three Net Income towards Common Stockholders figures came in at $23.1 million (Q1 2026), $30.9 million (Q4 2025), and $26.8 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Abbott Laboratories 152.92 Bn 146.27 Bn 6.27 Bn 1.08 Bn
2 Stryker 119.50 Bn 116.62 Bn 3.81 Bn 745.00 Mn
3 Medtronic 102.71 Bn 94.54 Bn 5.76 Bn 1.15 Bn
4 Boston Scientific 69.72 Bn 68.51 Bn 3.61 Bn 1.34 Bn
5 Edwards Lifesciences 49.24 Bn 45.57 Bn 1.29 Bn -
6 GE HealthCare Technologies 29.74 Bn 27.67 Bn 1.98 Bn 411.00 Mn
7 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 187,319.30
8 Dexcom 28.96 Bn 27.84 Bn 750.30 Mn 199.50 Mn
9 Steris 20.31 Bn 19.88 Bn 697.10 Mn -
10 LivaNova 4.34 Bn 3.76 Bn 243.75 Mn 23.15 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 23.15 Mn
Dec 31, 2025 30.92 Mn
Sep 30, 2025 26.80 Mn
Jun 30, 2025 27.17 Mn
Mar 31, 2025 -327.30 Mn
Dec 31, 2024 55.89 Mn
Sep 30, 2024 32.92 Mn
Jun 30, 2024 16.36 Mn
Mar 31, 2024 -41.92 Mn
Dec 31, 2023 16.36 Mn
Sep 30, 2023 -7.29 Mn
Jun 30, 2023 1.18 Mn
Mar 31, 2023 7.40 Mn
Dec 31, 2022 1.69 Mn
Sep 30, 2022 -107.40 Mn
Jun 30, 2022 16.49 Mn
Mar 31, 2022 3.03 Mn
Dec 31, 2020 -498,000.00
Mar 31, 2020 -995,000.00
Dec 31, 2019 187,000.00